FDA Adverse Event Injury Summary report: N

COCR FEMORAL HEAD

MDR report key: 7539954 · Received May 24, 2018

Report

Report Number
0001825034-2018-03514
Event Type
Injury
Date Received
May 24, 2018
Report Date
May 25, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
PMA / PMN Number
PK993438
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: 103535; SCREW; 088740, 13-104150; MALLORY HEAD SHELL; 429660, 103534; SCREW; 172440, X180309; BIMETRIC STEM; 666420, 11-105903; RINGLOC LINER; 034840. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS IT REMAINS IMPLANTED .REPORTED EVENT WAS CONFIRMED BY REVIEW OF RADIOGRAPHS. DEVICE HISTORY RECORD DHR WAS REVIEWED AND NO DISCREPANCIES RELEVANT TO THE REPORTED EVENT WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 1

(B)(4). UPON REASSESSMENT OF THE REPORTED EVENT, IT WAS DETERMINED THAT THIS DEVICE IS NOT REPORTABLE AS IT WAS NOT INVOLVED IN THE EVENT AND DID NOT MALFUNCTION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED A PATIENT HAS BEEN INDICATED FOR HIP REVISION APPROXIMATELY 13 YEARS POST-IMPLANTATION DUE TO LINER WEAR. NO REVISION HAS BEEN REPORTED TO DATE. SUBLUXATION WAS NOTED IN REVIEW OF X-RAYS. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
382282 COCR FEMORAL HEAD PROSTHESIS, HIP KWA ZIMMER BIOMET, INC. N/A 122780

Patients

Seq Age Sex Outcome Treatment
1 Other